UTILIZAREA LIGANDULUI FLT3
Price not visible for this package
Interest:
Assignment
Publication info:
No.: RO120579
Date: 28.04.2006
Inventor(s):
BRASEL KENNETH [US]
LYMAN STEWART D [US]
MARASKOVSKY EUGENE [US]
MCKENNA HILARY R [US]
LYNCH DAVID H [US]
Applicant(s):
IMMUNEX CORP [US]
Classification:
International patent classification (IPC):
A61K31/00; A61K35/12; A61K38/00; A61K38/18; A61K39/00; A61K39/21; A61K39/39; A61K45/00; A61P31/00; A61P31/18; A61P35/00; A61P37/00; A61P37/04; A61P43/00; C12N15/09; C12N5/0784; C12N5/10; A01N1/00
Cooperative patent classification (CPC):
A61K38/18 (EP); A61K39/39 (EP); A61K45/00 (KR); A61P31/00 (EP); A61P31/18 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P37/04 (EP); A61P43/00 (EP); C12N5/0639 (EP); A61K2039/5154 (EP); A61K2039/55516 (EP); A61K2039/55522 (EP); C12N2501/125 (EP); C12N2501/22 (EP); C12N2501/23 (EP); C12N2501/24 (EP); C12N2501/26 (EP); A61K39/39; A61K2300/00
Application info:
No.: RO19980000824
Date:
03.10.1996
Priority number(s):
US19950539142
04.10.1995
; WO1996US15990
03.10.1996
Related patents:
ATE432085; AU697539; AU7392296; BR9610802; CA2232865; CN1172718; CN1229359; CZ97798; EA199800272; EE9800105; EP0871487; ES2323818; IS4703; JP3631496; JPH11513389; KR100514957; KR100676792; KR19990063818; KR20040079421; LV12085; NO981374; NZ321039; PL187329; PL325964; SI9620116; SK40898; TR199800607; WO9712633
Description:
Invenţia se referă la utilizarea ligandului Flt3 în amplificarea unui răspuns imun la un pacient, utilizarea ligandului Flt3 în generarea in vivo sau in vitro şi la inducerea toleranţei faţă de grefa de ţesut, la o gazdă.